Drugs / Rhenium-186 sulfide
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT01615991 | May 2012 → Dec 2017 | arthritic joint disease | Centre de recherche du Centre hospitalier universitaire de Sherbrooke | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Rhenium-186 sulfide | “The goal of this study is to demonstrate Yttrium-90 citrate colloid or Rhenium-186 sulfide synovectomy are appropriate therapeutic interventions” NCT01615991 ↗ |